Stocks and Investing
Stocks and Investing
Wed, November 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Roberts Initiated (CC) at Sell and Held Target at $24 on, Nov 1st, 2022
John Roberts of Credit Suisse, Initiated "The Chemours Company" (CC) at Sell and Held Target at $24 on, Nov 1st, 2022.
John has made no other calls on CC in the last 4 months.
There are 7 other peers that have a rating on CC. Out of the 7 peers that are also analyzing CC, 5 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $33 on, Tuesday, October 25th, 2022
- Duffy Fischer of "Goldman Sachs" Initiated at Hold and Held Target at $30 on, Thursday, October 13th, 2022
- David Coleman of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, October 5th, 2022
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $30 on, Tuesday, September 27th, 2022
- Joshua Spector of "UBS" Maintained at Hold with Increased Target to $37 on, Friday, July 29th, 2022
These are the ratings of the 2 analyists that currently disagree with John
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $41 on, Thursday, October 27th, 2022
- Arun Viswanathan of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Thursday, September 22nd, 2022
Contributing Sources